Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cosmos Health Inc
(NQ:
COSM
)
0.7000
UNCHANGED
Streaming Delayed Price
Updated: 3:57 PM EDT, May 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cosmos Health Inc
< Previous
1
2
3
4
Next >
Cosmos Health Participated in Vitafoods Europe 2024; Receives Significant Interest and Numerous New Partnership Inquiries for its Sky Premium Life Nutraceuticals Brand
May 17, 2024
Via
ACCESSWIRE
Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K
April 19, 2024
Via
ACCESSWIRE
Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of its Next Generation AI Drug Repurposing Platform
March 21, 2024
Via
ACCESSWIRE
Cosmos Health To Receive Regulatory Approval for C-Scrub Disinfectant in the UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU, Eyeing Global $36Bn+ Market
March 19, 2024
Via
ACCESSWIRE
Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders
March 18, 2024
Via
ACCESSWIRE
Cosmos Health Successfully Completes Acquisition of Pharmatrade’s Assets; Expects to Increase FY 2024 Annual Revenue by over $5 Million
February 29, 2024
Via
ACCESSWIRE
Taglich Brothers Publishes First Coverage Report on Cosmos Health with a Price Target of $4, a Nearly Five-Fold Increase from Current Share Price
February 21, 2024
Via
ACCESSWIRE
Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company
February 20, 2024
Via
ACCESSWIRE
Taglich Brothers Initiates Coverage of Cosmos Health Inc.
February 01, 2024
Via
ACCESSWIRE
Cosmos Health Completes Acquisition of Cloudscreen, a Cutting-Edge AI Platform; Enters Lucrative $25Bn+ Global Drug Repurposing Market
January 23, 2024
Via
ACCESSWIRE
Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio
January 18, 2024
Via
ACCESSWIRE
Cosmos Health Set for Substantial Growth From Acquisitions Completed in 2023
December 27, 2023
Via
ACCESSWIRE
Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X
December 20, 2023
Via
ACCESSWIRE
Cosmos Health Announces Open Market Stock Purchases by the CEO
December 18, 2023
Via
ACCESSWIRE
Cosmos Health to Participate at Capital Link’s 'Invest in Greece' Forum in New York
December 08, 2023
Via
ACCESSWIRE
Cosmos Health Enters into Agreement to Acquire Rights for WIPO-Filed Patent on Drug Targeting CNS Cancers
December 07, 2023
Via
ACCESSWIRE
Cosmos Health Announces Patent Filing for its Obesity and Weight Management Product
December 01, 2023
Via
ACCESSWIRE
Cosmos Health Reports Q3 2023 Results; Revenue Increased 7% YoY, Total Assets Reached Record $71.5M with Stockholders' Equity of $44.2M or $3.4/Share
November 21, 2023
Via
ACCESSWIRE
Cosmos Health to Acquire Cloudscreen, a Cutting-Edge AI-Powered Drug Repurposing Platform; Anticipated to Establish Cosmos as a Leader in the $25Bn Global Market and Deliver Unparalleled Returns for Shareholders
October 11, 2023
Via
ACCESSWIRE
COSMOS HEALTH CEO Issues Letter to Shareholders
October 05, 2023
Via
ACCESSWIRE
Cosmos Health Actively Exploring Spinoff of R&D Division into a Publicly Listed Standalone Biotech Company
September 27, 2023
Via
ACCESSWIRE
Cosmos Health Announces Expansion of Its C-Sept Brand with the Launch of C-Scrub Wash; Capitalizing on $29 Billion Global Antiseptic and Disinfectant Market
September 26, 2023
Via
ACCESSWIRE
Cosmos Health Announces Relaunch of bio-bebe(R), its Proprietary Organic Infant Care & Nutrition Brand; Aims to Penetrate $103bn Global Baby Food Market
September 21, 2023
Via
ACCESSWIRE
Cosmos Health Announces Strategic Collaboration with C.A.PAPAELLINAS Group
September 20, 2023
Via
ACCESSWIRE
Cosmos Health Starts Stock Buyback Program
September 13, 2023
Via
ACCESSWIRE
BestGrowthStocks.com issues New Growth Report on Cosmos Health
September 13, 2023
NEW YORK, NY / NewsDirect / September 13th, 2023 / Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks...
Via
TheNewswire.com
Cosmos Health Introduces Guidance; Expects to Achieve Over $180M in Gross Annual Revenue and EBITDA in Excess of $20M by 2026; Recaps Significant Events Reported So Far in 2023
September 12, 2023
Via
ACCESSWIRE
Cosmos Health Reports Q2 2023 Financial Results; Adjusted Net Income Increases by 3550% to Surpass $3 Million for H1 2023 vs $(0.09) Million H1 2022; Book Value per Share Exceeds $4.04
August 15, 2023
Via
ACCESSWIRE
Cosmos Health Appoints Big 4 Accounting Firm KPMG as Auditor
August 08, 2023
Via
ACCESSWIRE
Cosmos Health Continues to Expand Mediterranation Brand, Welcomes Eleonas and Olympus Mons; Boosts Exports and Secures Purchase Orders, Including from Leading Multinational Health Food Chain
August 02, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.